Takaharu Oue
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Takaharu Oue has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
- Masahiro Zenitani
Department of Pediatric Surgery, Osaka Women’s and Children’s Hospital, Izumi, Japan
6 shared publications - Takashi Sasaki
Department of Pediatric Surgery Osaka City General Hospital Osaka Japan
4 shared publications - Eiso Hiyama
Natural Science Center for Basic Research and Development, Hiroshima University, Hiroshima 734-8553, Japan
3 shared publications Tetsuya Takimoto
Department of Childhood Cancer Data Management, National Center for Child Health and Development, Tokyo, Japan
3 shared publications- Tomoro Hishiki
Department of Pediatric Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan
3 shared publications Tsugumichi Koshinaga
Department of Pediatric Surgery, Nihon University School of Medicine, Tokyo, Japan
3 shared publications
Latest Publications
- Open Access
- 11 September 2026
- Published by Springer Nature in Pediatric Surgery International
- Vol. 42 (1) , 399
Biotube/Biosheet as a collagen-based scaffold for vaginal reconstruction: evaluation in a rat model
Purpose Biotube/Biosheet, collagenous tissue membranes generated by in-body tissue architecture, have been used as scaffolds in various tissue engineering applications. However, their use in vaginal reconstruction has not been reported. This study aimed to evaluate the biocompatibility and potential utility of Biotube/Biosheet as scaffolds for vaginal reconstruction in a rat model. Methods A cylindrical mold was implanted subcutaneously on the backs of rats to generate Biotube/Biosheet. Two models were established: a partial defect of the posterior vaginal wall and a complete circumferential implantation. In each model, trimmed Biotube/Biosheet was sutured into place. Rats were euthanized 4 to 14 days after surgery for macroscopic and histological evaluation. Results An epithelial extension from the residual vagina along the luminal surface of the Biotube/Biosheet was observed and eventually reached the vaginal orifice, resulting in complete mucosal coverage. The Biotube/Biosheet was gradually infiltrated and replaced by granulation tissue, and muscular tissue extended toward the vaginal orifice. No neutrophil or lymphocyte infiltration suggestive of acute rejection was detected. Conclusion Biotube/Biosheet shows promise as a scaffold for vaginal reconstruction. Long-term follow-up studies are needed to determine whether it is fully replaced by normal vaginal tissue and whether the reconstructed vagina can support pregnancy and childbirth.
- 11 September 2026
- Published by Springer Nature in Pediatric Surgery International
- Vol. 42 (1) , 399
Open AccessBiotube/Biosheet as a collagen-based scaffold for vaginal reconstruction: evaluation in a rat model
Purpose Biotube/Biosheet, collagenous tissue membranes generated by in-body tissue architecture, have been used as scaffolds in various tissue engineering applications. However, their use in vaginal reconstruction has not been reported. This study aimed to evaluate the biocompatibility and potential utility of Biotube/Biosheet as scaffolds for vaginal reconstruction in a rat model. Methods A cylindrical mold was implanted subcutaneously on the backs of rats to generate Biotube/Biosheet. Two models were established: a partial defect of the posterior vaginal wall and a complete circumferential implantation. In each model, trimmed Biotube/Biosheet was sutured into place. Rats were euthanized 4 to 14 days after surgery for macroscopic and histological evaluation. Results An epithelial extension from the residual vagina along the luminal surface of the Biotube/Biosheet was observed and eventually reached the vaginal orifice, resulting in complete mucosal coverage. The Biotube/Biosheet was gradually infiltrated and replaced by granulation tissue, and muscular tissue extended toward the vaginal orifice. No neutrophil or lymphocyte infiltration suggestive of acute rejection was detected. Conclusion Biotube/Biosheet shows promise as a scaffold for vaginal reconstruction. Long-term follow-up studies are needed to determine whether it is fully replaced by normal vaginal tissue and whether the reconstructed vagina can support pregnancy and childbirth.
- 14 June 2022
- Published by S. Karger AG in Annals of Nutrition and Metabolism
- Vol. 78 (6) , 345-351
Clinical Usefulness of Blenderized Food for Selenium Deficiency in Pediatric Patients with Severe Motor and Intellectual Disabilities
Introduction: This study aimed to assess the preventive or therapeutic effects of blenderized food (BF) on selenium deficiency in pediatric patients with severe motor and intellectual disabilities (SMID). Methods: The medical records of all 40 consecutive pediatric patients with SMID who underwent nutritional assessment were retrospectively reviewed and compared between two groups: the enteral formula (EF) group and the BF group fed with BF providing more than 10% of total caloric intake. Next, for the selenium-deficient patients who were newly started on blenderized tube feeds after the first nutritional assessment, improvement of selenium deficiency and change of dietary contents were assessed. Results: The BF group patients had a significantly lower prevalence of selenium deficiency and higher serum selenium levels than the EF group patients. In all 7 selenium-deficient patients who started blenderized tube feeds after the first nutritional assessment, serum selenium levels were significantly increased at the second nutritional assessment, even though total selenium intake, selenium intake by EF, and total caloric intake did not differ significantly, and, in fact, caloric intake was significantly decreased by EF. Conclusion: Combined feeding of BFs can be useful for prevention and therapy of selenium deficiency in pediatric SMID patients.
- 14 June 2022
- Published by S. Karger AG in Annals of Nutrition and Metabolism
- Vol. 78 (6) , 345-351
Clinical Usefulness of Blenderized Food for Selenium Deficiency in Pediatric Patients with Severe Motor and Intellectual Disabilities
Introduction: This study aimed to assess the preventive or therapeutic effects of blenderized food (BF) on selenium deficiency in pediatric patients with severe motor and intellectual disabilities (SMID). Methods: The medical records of all 40 consecutive pediatric patients with SMID who underwent nutritional assessment were retrospectively reviewed and compared between two groups: the enteral formula (EF) group and the BF group fed with BF providing more than 10% of total caloric intake. Next, for the selenium-deficient patients who were newly started on blenderized tube feeds after the first nutritional assessment, improvement of selenium deficiency and change of dietary contents were assessed. Results: The BF group patients had a significantly lower prevalence of selenium deficiency and higher serum selenium levels than the EF group patients. In all 7 selenium-deficient patients who started blenderized tube feeds after the first nutritional assessment, serum selenium levels were significantly increased at the second nutritional assessment, even though total selenium intake, selenium intake by EF, and total caloric intake did not differ significantly, and, in fact, caloric intake was significantly decreased by EF. Conclusion: Combined feeding of BFs can be useful for prevention and therapy of selenium deficiency in pediatric SMID patients.
- Open Access
Feasibility of Real-Time Central Surgical Review for Patients with Advanced-Stage Hepatoblastoma in the JPLT3 Trial
In the JPLT3 study, a real-time central surgical reviewing (CSR) system was employed aimed at facilitating early referral of candidates for liver transplantation (LTx) to centers with pediatric LTx services. The expected consequence was surgery, including LTx, conducted at the appropriate time in all cases. This study aimed to review the effect of CSR on institutional surgical decisions in cases enrolled in the JPLT3 study. Real-time CSR was performed in cases in which complex surgeries were expected, using images obtained after two courses of preoperative chemotherapy. Using the cloud-based remote image viewing system, an expert panel consisting of pediatric and transplant surgeons reviewed the images and commented on the expected surgical strategy or the necessity of transferring the patient to a transplant unit. The results were summarized and reported to the treating institutions. A total of 41 reviews were conducted for 35 patients, and 16 cases were evaluated as possible candidates for LTx, with the treating institutions being advised to consult a transplant center. Most of the reviewed cases promptly underwent definitive liver surgeries, including LTx per protocol.
Open AccessFeasibility of Real-Time Central Surgical Review for Patients with Advanced-Stage Hepatoblastoma in the JPLT3 Trial
In the JPLT3 study, a real-time central surgical reviewing (CSR) system was employed aimed at facilitating early referral of candidates for liver transplantation (LTx) to centers with pediatric LTx services. The expected consequence was surgery, including LTx, conducted at the appropriate time in all cases. This study aimed to review the effect of CSR on institutional surgical decisions in cases enrolled in the JPLT3 study. Real-time CSR was performed in cases in which complex surgeries were expected, using images obtained after two courses of preoperative chemotherapy. Using the cloud-based remote image viewing system, an expert panel consisting of pediatric and transplant surgeons reviewed the images and commented on the expected surgical strategy or the necessity of transferring the patient to a transplant unit. The results were summarized and reported to the treating institutions. A total of 41 reviews were conducted for 35 patients, and 16 cases were evaluated as possible candidates for LTx, with the treating institutions being advised to consult a transplant center. Most of the reviewed cases promptly underwent definitive liver surgeries, including LTx per protocol.
- 1 July 2021
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 56 (7) , 1211-1218
Kampo medicines Rikkunshito and Hangeshashinto prevent cisplatin-induced intestinal mucosal injury in rats
- 1 July 2021
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 56 (7) , 1211-1218
Kampo medicines Rikkunshito and Hangeshashinto prevent cisplatin-induced intestinal mucosal injury in rats
- 8 August 2019
- Published by Springer Nature in Pediatric Surgery International
- Vol. 35 (10) , 1095-1099
Factors responsible for stage III disease in patients with Wilms tumor enrolled in the JWiTS-2 study
Background/objectives Treatment is more intensive for stage III Wilms tumor (WT) than for stages I and II non-metastatic WTs. Various factors including tumor spillage, unresectability, and lymph node metastasis are responsible for stage III disease. The present study aimed to not identify clinical factors associated with the features of stage III WT to establish new treatment strategies. Design/methods Of 166 patients with non-metastatic WT enrolled in the Japan Wilms Tumor Study (JWiTS)-2, 51 patients had stage III disease. The treatment protocol for JWiTS-2 was essentially the same as that in the National Wilms Tumor study (NWTS)-5. Local hospitals were surveyed to collect details of clinical findings related to stage III disease, and data regarding 45 (88%) patients were obtained. Results Nine patients with massive tumors underwent preoperative chemotherapy. Biopsy was performed in 6. Reduction in the tumor size was achieved in 8 of the 9 cases. Nephrectomy was finally performed in all of them. Thirty-six patients underwent primary nephrectomy. The reason for the stage III disease was lymph node metastasis (n = 9, 25%), tumor spillage (n = 20, 56%), and tumor extension/incomplete resection (n = 17, 47%). Some patients had more than one of these factors. Most patients were treated with the DD-4A regimen, and 43 (95.6%) of the 45 patients received abdominal radiation therapy. Tumors recurred in three patients (local, 1; metastasis, 2), and two patients died. Overall and relapse-free survival rates were 95.2% and 90.8%, respectively. Conclusion The prognosis of stage III WT was good. In the next stage, the doses of chemotherapy and radiotherapy should be reduced to avoid late effects. The high rate of tumor spillage after primary resection suggests that preoperative chemotherapy should be started instead of aggressive tumor resection in the large tumor cases with surgical risks
- 8 August 2019
- Published by Springer Nature in Pediatric Surgery International
- Vol. 35 (10) , 1095-1099
Factors responsible for stage III disease in patients with Wilms tumor enrolled in the JWiTS-2 study
Background/objectives Treatment is more intensive for stage III Wilms tumor (WT) than for stages I and II non-metastatic WTs. Various factors including tumor spillage, unresectability, and lymph node metastasis are responsible for stage III disease. The present study aimed to not identify clinical factors associated with the features of stage III WT to establish new treatment strategies. Design/methods Of 166 patients with non-metastatic WT enrolled in the Japan Wilms Tumor Study (JWiTS)-2, 51 patients had stage III disease. The treatment protocol for JWiTS-2 was essentially the same as that in the National Wilms Tumor study (NWTS)-5. Local hospitals were surveyed to collect details of clinical findings related to stage III disease, and data regarding 45 (88%) patients were obtained. Results Nine patients with massive tumors underwent preoperative chemotherapy. Biopsy was performed in 6. Reduction in the tumor size was achieved in 8 of the 9 cases. Nephrectomy was finally performed in all of them. Thirty-six patients underwent primary nephrectomy. The reason for the stage III disease was lymph node metastasis (n = 9, 25%), tumor spillage (n = 20, 56%), and tumor extension/incomplete resection (n = 17, 47%). Some patients had more than one of these factors. Most patients were treated with the DD-4A regimen, and 43 (95.6%) of the 45 patients received abdominal radiation therapy. Tumors recurred in three patients (local, 1; metastasis, 2), and two patients died. Overall and relapse-free survival rates were 95.2% and 90.8%, respectively. Conclusion The prognosis of stage III WT was good. In the next stage, the doses of chemotherapy and radiotherapy should be reduced to avoid late effects. The high rate of tumor spillage after primary resection suggests that preoperative chemotherapy should be started instead of aggressive tumor resection in the large tumor cases with surgical risks
- 1 July 2018
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 53 (7) , 1288-1294
Umbilical appearance and patient/parent satisfaction over 5 years of follow-up after umbilical hernia repair in children
- 1 July 2018
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 53 (7) , 1288-1294
Umbilical appearance and patient/parent satisfaction over 5 years of follow-up after umbilical hernia repair in children
- Open Access
- 1 February 2018
- Published by Elsevier in Journal of Pediatric Surgery Case Reports
- Vol. 29, 71-73
Omental flap repair for re-recurrent tracheoesophageal fistula 21 years after primary esophageal atresia repair
- 1 February 2018
- Published by Elsevier in Journal of Pediatric Surgery Case Reports
- Vol. 29, 71-73
Open AccessOmental flap repair for re-recurrent tracheoesophageal fistula 21 years after primary esophageal atresia repair
- 8 November 2017
- Published by Springer Nature in Pediatric Surgery International
- Vol. 34 (1) , 29-34
Image-based surgical risk factors for Wilms tumor
The standard treatment for Wilms tumor (WT) is primary resection. However, in cases with unresectable tumor or tumor spillage, which are considered to have high surgical risks, more intensive chemotherapy and radiotherapy are required. In the present study, we retrospectively analyzed preoperative image parameters to identify factors associated with surgical risks.
- 8 November 2017
- Published by Springer Nature in Pediatric Surgery International
- Vol. 34 (1) , 29-34
Image-based surgical risk factors for Wilms tumor
The standard treatment for Wilms tumor (WT) is primary resection. However, in cases with unresectable tumor or tumor spillage, which are considered to have high surgical risks, more intensive chemotherapy and radiotherapy are required. In the present study, we retrospectively analyzed preoperative image parameters to identify factors associated with surgical risks.
- 29 July 2016
- Published by Springer Nature in Pediatric Surgery International
- Vol. 32 (9) , 851-855
Anaplastic histology Wilms’ tumors registered to the Japan Wilms’ Tumor Study Group are less aggressive than that in the National Wilms’ Tumor Study 5
To evaluate the clinical features and treatment results of anaplastic histology (AH) Wilms’ tumor (WT) patients registered in the Japan Wilms’ Tumor Study (JWiTS) group to elucidate the clinical characteristics of AH in the Japanese population.
- 29 July 2016
- Published by Springer Nature in Pediatric Surgery International
- Vol. 32 (9) , 851-855
Anaplastic histology Wilms’ tumors registered to the Japan Wilms’ Tumor Study Group are less aggressive than that in the National Wilms’ Tumor Study 5
To evaluate the clinical features and treatment results of anaplastic histology (AH) Wilms’ tumor (WT) patients registered in the Japan Wilms’ Tumor Study (JWiTS) group to elucidate the clinical characteristics of AH in the Japanese population.